This presentation takes a look at an area of women’s health where AI and technology have had a profound impact in increasing access and improving outcomes through next generation imaging. Hear from experts leading the way as they unpack the latest developments and discuss it’s potential to transform women’s cancer outcomes
Join this session to learn about how recent understandings of the ways that women present differently from men in various disease areas have impacted the delivery and design of clinical trials to account for sex differences. Hear about the latest innovations driving change, including the role that AI and ML play in stratifying populations, and how remote clinical trials and telehealth are increasing access to clinical trials. Both of these factors play a crucial role in ensuring that more diversity and sex-focused trials take place
Lisa Suennen
With an increase in publishing guidelines calling for more sex and gender specific research and better diversity and inclusion in clinical trials, this panel discussion considers how to promote accountability across the public and private sphere. How can we ensure that guidelines are adhered to and what role do public-private sector partnerships play in promoting better research practices? What do recent guidelines published by the FDA advocating for health equity in clinical trials really mean for those innovation in the space? Join this session to unpack these questions and to gain insight into how to ensure your business is successfully considering sex and gender throughout the R&D process.
Hadine Joffee
Sentara Health Plans
Ontrak Health
Kidron Capital
American Heart Association
Brigham and Women’s Hospital
AI presents an exciting opportunity to augment behavioural health delivery by enhancing access to care. Join this session to hear from those innovating at the forefront of this disruptive space as they outline the opportunities to improve women’s mental health.
Jasmi Shah
Brianna Brennan
Tamika Lane, MSN, RN, CCM
As the healthcare services sector gains prominence in investment circles, the women’s health industry faces a pressing question: how can it adapt to meet evolving demands? This discussion deep dives into this pivotal issue, exploring how collaboration stands as a linchpin for driving consolidation through collaboration in the years ahead. Join industry leaders as they underscore the imperative of establishing pathways for founders to seamlessly integrate and aggregate their solutions while protecting their IP. Discover how this collaborative approach streamlines offerings for the end customer and creates a pathway for founders, ensuring a surplus of services without sacrificing quality or accessibility.